Product details
Catalog number P015-568-125
Price for P015-568-125
Size / count 1x 125 µL
CD9 (2310.9) is a recombinant mouse monoclonal antibody that recognizes the human tetraspanin protein CD9. This CF®568 antibody conjugate has been validated in flow cytometry. It is supplied at 5 uL/test, with sufficient antibody for 25 tests.
The catalog number for CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is P015-568-125.
CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is available in the following size(s): 1x 125 µL.
CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is currently made to order / not held in immediate stock. Contact us for lead time.
CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is manufactured by Biotium.
Estimated delivery time for CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is approximately 15 business day(s), depending on your location.
The safety data sheet for CD9 Recombinant Monoclonal Mouse Antibody (2310.9), CF®568 Conjugate - Biotium Choice is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.
CD9 (2310.9) is a recombinant mouse monoclonal antibody that recognizes the human tetraspanin protein CD9. This CF®568 antibody conjugate has been validated in flow cytometry. It is supplied at 5 uL/test, with sufficient antibody for 25 tests.
Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.
Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.
Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.